Valuation

Valuation

  • Goods valuation for EEI

    QUESTION: In the FTR 30.1(c) the export value of goods is defined to include the freight and insurance to the port of export. If goods are sold ex works is the freight and insurance required to be included on the EEI value of goods? Do incoterms affect the value of goods reported on the EEI? […]

  • ASSET VALUATION

    QUESTION: We manage client assets and originally sold the assets to them. If the asset is a few years old and needs to cross the border and we only have the original sales price of the asset, is this sufficient to declare as a customs value? Although we manage the assets, we don’t own them. […]

  • Related Parties, Reasonable Care, and Deductive Value

    QUESTION: I have some questions related to valuation for related party transactions that I have not found in other resources. Most of our imports are from related parties. Some of these materials are finished goods, some of components that will be assembled with other materials to comprise a finished good, and still others are simply […]

  • CBP Pipeline – Imported Value

    QUESTION: CBP published a “Pipeline” on January 11, 2017 with 3 options for declaring imported value on a DSP 61 or DSP 73. http://www.icpainc.org/wp-content/uploads/2014/10/ICPA-Department-of-State-Import-and-Export-Electronic-Filings-for-Licenses-and-Exemptions-Bulletin.pdf An example is given for a part that has been exported for $750, and had $350 of repair work. According to CBP, upon importation the importer can: 1. Declare $1100 against […]

  • CUSTOMS VALUE DEFECTIVE ITEM SCENARIO

    QUESTION: A customer returned product to our Chinese entity because it was defective. Due to currency control restrictions and difficulty getting money out of China the China entity is considering to reimburse the customer via a discount in the amount of the defective goods on the next commercial invoice. Is the transaction value on the […]

  • STOCK TRANSFER VALUATION

    QUESTION: Will any of the members have experience in proper customs valuation on Inventory Stock Transfer? We are a Canadian company that will be transferring inventories to a related-party Warehouse in the USA for future sales order fulfillment. When the goods are being transfer in the US, we will Customs duty pay for these inventories. […]

  • Are prospective Transfer Price Adjustments allowable in lieu of retrospective TP adjustments?

    QUESTION: The company I work for is considering to forego retrospective transfer price adjustments and just move forward with “prospective” transfer price adjustments. The way the tax team explained it to me is that they will capture any profitability issues in the true up “next year”. They advise that this should resolve any need to […]

  • PREPAYMENT AND IMPORT VALUATION

    QUESTION: We have a customer who wants to prepay for shipments as a way to hedge against currency fluctuations. They would send a Pro Forma Invoice with an amount and a few Part Numbers that they buy from us, but not necessarily the PNs they will buy from us on the next order. They will […]

  • C’NEE VALUE ADJUSTMENTS

    QUESTION: We are sourcing and shipping materials to a collaborator in the EU for testing as part of a project. We issue our proforma invoices using the actual values paid for the materials we are sending, we are not selling the materials to them. We have just found out that the recipient is adjusting the […]

  • Setting Transfer Prices – duty and taxes included?

    QUESTION: I recently spoke with the tax and finance team about how they set transfer prices and what is included in the calculation. When we started speaking about TP I advised them that duty would be assessed on the entered value which is the TP (assuming Customs accepts TP as the TV).  They responded, we […]

  • HIGH PSC VALUATION ISSUE

    QUESTION: We have determined that our transfer pricing model with our related party supplier is valid for use under Customs transaction value methodology. We are not in recon despite my recommendations in previous years. I just learned that my company will be receiving credits (adjustments to unit value) from our related party supplier for numerous […]

  • Clinical Drug Valuation

    QUESTION: My company is revamping its clinical valuation practices and I’m wondering if anyone has insight as to methodologies for valuing commercially approved drugs to be used in the clinical space for reindications or as comparators.  It is my understanding that since there is no price paid or payable, one would seek to use the […]